Arisaema cum bile formula granules and preparation method thereof

By optimizing the soaking, decoding and drying process of Dannanxing decoction and combining with the dry pressing granulation of dextrin, the problem of uneven quality of Dannanxing formula granules is solved, the extraction rate and stability are improved, the preparation process is simplified and the cost is reduced.

CN119074839APending Publication Date: 2024-12-06ZHONGJING WANXI PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411278473.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-12
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The quality of the pellets of Dannanxing formula are uneven and difficult to meet quality standards, which affects their stability and application effect.

Method used

By soaking Dannanxing decoction with water in a preset ratio, decocting and extracting, concentrating and spray-drying, combining the dry press granulation process of dextrin, optimizing the number of decoction times, time and pelletizing machine parameters, the best preparation conditions are determined. Improve extraction rate and quality.

Benefits of technology

The quality consistency and stability of the Chronin formula particles is achieved, the extraction effect of active ingredients is improved, the preparation process is simplified, and energy consumption and cost are reduced.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119074839A_ABST
    Figure CN119074839A_ABST
Patent Text Reader

Abstract

The invention provides arisaema cum bile formula granules and a preparation method thereof, and the preparation method comprises the following steps: step S100, adding arisaema cum bile decoction pieces and water into an extraction container according to a first preset proportion, and soaking the arisaema cum bile decoction pieces; and step S200, decocting and extracting to obtain an arisaema cum bile filtrate. And step S300, concentrating the arisaema cum bile filtrate to obtain a clear paste. And step S400, taking the clear paste, and performing spray drying to obtain dry paste powder. And step S500, mixing the dry paste powder with dextrin in a second preset proportion, and performing dry pressing to prepare the arisaema cum bile formula granules. According to the arisaema cum bile formula granules and the preparation method thereof, the problem that the quality of the arisaema cum bile formula granules is uneven can be solved, and the effect that the arisaema cum bile formula granules meet the quality standard is achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of traditional Chinese medicine formula granules, in particular to a kind of Arisaema ciliata formula granules and a preparation method thereof. Background Art

[0002] Arisaema ciliata is made from raw arisaema powder and cow, sheep or pig bile through fermentation. Arisaema ciliata is good at clearing away heat and phlegm, calming wind and calming convulsions. It is used for cough due to phlegm heat, yellow and thick phlegm, phlegm congestion caused by stroke, epilepsy and convulsions. It is often used clinically for phlegm heat, cough and asthma, epilepsy and acute convulsions. Modern pharmacological studies have shown that Arisaema ciliata has analgesic, anti-inflammatory and sedative effects, without obvious adverse reactions, and therefore plays an irreplaceable role in clinical practice.

[0003] The formula granules of Arisaema ciliata are granules made by water heating extraction, separation, concentration, drying and granulation of Arisaema ciliata slices. The formula granules of Arisaema ciliata effectively avoid the situation that Chinese patent medicines are difficult to add or subtract according to symptoms, and are convenient to store and carry, making it more convenient to take medicine. The quality of Arisaema ciliata granules prepared under different process conditions varies. It is necessary to study and optimize the preparation process of Arisaema ciliata granules so that the Arisaema ciliata granules meet the quality standards, and then control the stability of the quality of the Arisaema ciliata granules. Summary of the invention

[0004] In view of the above problems, the present invention is proposed to provide a kind of Arisaema consanguineum formula granules and a preparation method thereof that overcome the above problems or at least partially solve the above problems, which can solve the problem of uneven quality of Arisaema consanguineum formula granules and achieve the effect of making Arisaema consanguineum formula granules meet the quality standards.

[0005] Specifically, the present invention provides a method for preparing a granule of Arisaema ciliata formula, comprising the following steps: Putting Arisaema ciliata slices and water into an extraction container according to a first preset ratio to soak the Arisaema ciliata slices; Decoction and extraction to obtain the filtrate of Arisaema ciliata; The filtrate of Arisaema ciliata is concentrated to obtain a clear paste; Taking the clear paste and spray drying it to obtain dry paste powder; The dry paste powder is mixed with dextrin in a second preset ratio and then dry-pressed to prepare the bile linden formula granules.

[0006] Optionally, the decoction and extraction to obtain the Arisaema ciliata filtrate comprises: The extraction is performed at least once in the extraction container, and the Arisaema ciliata filtrate is obtained by decocting and extracting. Optionally, the first preset ratio is a weight ratio of the water to the Arisaema ciliata decoction pieces, and the first preset ratio is 10:1 to 15:1; The second preset ratio is a weight ratio of the dextrin to the dry paste powder, and the second preset ratio is less than or equal to 1; The soaking time is 0.5h to 2h, and the soaking temperature is 10°C to 40°C; The decoction temperature is 98°C to 100°C, and the decoction time is 0.5h to 2h; In the step of concentrating the filtrate of Arisaema confusa to obtain a clear paste, the concentration temperature is 50° C. to 85° C.; the relative density of the clear paste is 1.01 to 1.10; In the step of spray drying the clear paste to obtain dry paste powder, the inlet air temperature is 120°C to 180°C, and the outlet air temperature is 80°C to 110°C.

[0007] Optionally, after the dry paste powder is mixed with the second preset ratio of dextrin and then dry-pressed to obtain the bile linseed formula granules, the method further comprises: The preparation method of the Arisaema consanguineum formula granules is optimized.

[0008] Optionally, the step of putting Arisaema ciliata slices and water into an extraction container according to a first preset ratio to soak the Arisaema ciliata slices comprises: The Arisaema ciliata decoction pieces are cut into Arisaema ciliata granules by using a granulator, and the Arisaema ciliata granules and water are put into an extraction container according to the first preset ratio to soak the Arisaema ciliata granules.

[0009] Optionally, the method for preparing the Arisaema consanguineum formula granules is optimized, comprising: The aperture and granulation times of the pelletizer were tested for the preparation of the bile arborvitae formula granules, the paste yield and uracil content were analyzed, and bile acid identification was performed to determine the optimal aperture and optimal granulation times of the pelletizer.

[0010] Optionally, the method for preparing the Arisaema consanguineum formula granules is optimized, comprising: Single factor test and orthogonal test are performed on the number of decoctions, the decoction time, the first preset ratio, and the soaking time to obtain the paste yield, maximum paste yield, uracil content, maximum uracil content, bile acid identification score, and maximum bile acid identification score of each group of experiments; Determining a comprehensive score according to the cream yield rate, the maximum cream yield rate, the uracil content, the maximum uracil content, the bile acid identification score, and the highest bile acid identification score; Comparing the comprehensive scores, taking the process conditions corresponding to the highest comprehensive score as the optimal preparation conditions of the Dannanxing formula granules; Using the optimized process conditions of the Arisaema consanguineum formula granules, the optimized Arisaema consanguineum formula granules samples were prepared and analyzed, and the optimization results were verified by comparing with the control samples.

[0011] Optionally, in the step of determining a comprehensive score according to the cream yield, the maximum cream yield, the uracil content, the maximum uracil content, the bile acid identification score and the highest bile acid identification score, the calculation formula of the comprehensive score is: ; Among them, W is the comprehensive score; A1 is the cream yield rate, A0 is the maximum cream yield rate, a is the first coefficient; B1 is the uracil content, B0 is the maximum uracil content, b is the second coefficient; C1 is the bile acid identification score, C0 is the highest bile acid identification score, and c is the third coefficient.

[0012] Optionally, the first coefficient is 0.2; The second coefficient is 0.5; The third coefficient is 0.3.

[0013] The present invention also provides a kind of Arisaema consanguineum formula granules prepared by any one of the preparation methods described above.

[0014] In a kind of Arisaema ciliata formula granules and preparation method thereof of the present invention, when preparing Arisaema ciliata formula granules, Arisaema ciliata slices are soaked in water, and after soaking, the water is heated to boiling and decocted to obtain Arisaema ciliata filtrate. The Arisaema ciliata filtrate is concentrated and dried to obtain dry paste powder. The dry paste powder is mixed with dextrin and then dry-pressed to obtain Arisaema ciliata formula granules. After the Arisaema ciliata slices are soaked, water enters the tissue cells through osmosis, the Arisaema ciliata slices become soft, and the cells swell, which is more conducive to the dissolution of the active ingredients in the Arisaema ciliata slices. Moreover, the active ingredients in the Arisaema ciliata slices are easier to be extracted by water in the subsequent decoction process, thereby improving the extraction rate of the active ingredients. The decoction process has a high temperature, which can destroy the cell wall, so that the active ingredients wrapped in the cell wall and the cell membrane are released, so that the active ingredients in the Arisaema ciliata slices are dissolved in water faster and more completely, thereby improving the extraction effect of the Arisaema ciliata slices and improving the quality of the Arisaema ciliata formula granules.

[0015] Based on the following detailed description of specific embodiments of the present invention in conjunction with the accompanying drawings, those skilled in the art will become more aware of the above and other objects, advantages and features of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Hereinafter, some specific embodiments of the present invention will be described in detail in an exemplary and non-limiting manner with reference to the accompanying drawings. The same reference numerals in the accompanying drawings indicate the same or similar components or parts. It should be understood by those skilled in the art that these drawings are not necessarily drawn to scale. In the accompanying drawings: Figure 1is a schematic flow chart of a method for preparing a gallbladder aconite formula granule according to an embodiment of the present invention; Figure 2 is a schematic flow chart of optimizing the preparation method of Arisaema consanguineum formula granules according to one embodiment of the present invention; Figure 3 is a specific schematic flow chart of a method for preparing a gallbladder arisaema formula granule according to an embodiment of the present invention; Figure 4 It is the characteristic spectrum of the formula granules of Dannanxing and the reference medicinal materials; Figure 5 It is the thin layer chromatogram of the formula granules of Gastrodia elata and bile acid reference substance. DETAILED DESCRIPTION

[0017] Refer to the following Figures 1 to 5 To describe a kind of cholerae formula granules and preparation method thereof according to an embodiment of the present invention. In the description of this embodiment, it should be understood that the terms "first" and "second" are used for descriptive purposes only, and cannot be understood as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Thus, the features defined as "first" and "second" may explicitly or implicitly include at least one of the features, that is, include one or more of the features. In the description of the present invention, the meaning of "multiple" is at least two, such as two, three, etc., unless otherwise clearly and specifically defined. When a feature "includes or contains" one or some of the features it covers, unless otherwise specifically described, this indicates that other features are not excluded and other features may be further included.

[0018] In the description of the present embodiment, the description with reference to the terms "one embodiment", "some embodiments", "illustrative embodiments", "examples", "specific examples", or "some examples" means that the specific features, structures, materials, or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representation of the above terms does not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials, or characteristics described may be combined in any one or more embodiments or examples in a suitable manner.

[0019] Figure 1 is a schematic flow chart of a method for preparing a gallbladder aconite formula granule according to an embodiment of the present invention, such as Figure 1 As shown, and refer to Figures 2 to 5 The present invention provides a method for preparing a granule of Arisaema ciliata formula, comprising the following steps: Step S100, putting Arisaema ciliata slices and water into an extraction container according to a first preset ratio to soak the Arisaema ciliata slices.

[0020] Step S200, decoction and extraction to obtain Arisaema ciliata filtrate.

[0021] Step S300, concentrating the Arisaema ciliata filtrate to obtain a clear paste.

[0022] Step S400, taking the clear paste and spray drying it to obtain dry paste powder.

[0023] Step S500, taking the dry paste powder and the dextrin of the second preset ratio, mixing them and dry pressing them to obtain the Arisaema consanguineum formula granules.

[0024] In this embodiment, when preparing the Arisaema ciliata formula granules, the Arisaema ciliata slices are soaked in water, and after soaking, the water is heated to boiling and decocted to obtain the Arisaema ciliata filtrate. The Arisaema ciliata filtrate is concentrated and dried to obtain a dry paste powder. The dry paste powder is mixed with dextrin and then dry-pressed to obtain the Arisaema ciliata formula granules. After the Arisaema ciliata slices are soaked, water enters the tissue cells through osmosis, the Arisaema ciliata slices become soft, and the cells swell, which is more conducive to the dissolution of the active ingredients in the Arisaema ciliata slices. Moreover, the active ingredients in the Arisaema ciliata slices are easier to be extracted by water in the subsequent decoction process, thereby improving the extraction rate of the active ingredients. The high temperature of the decoction process can destroy the cell wall, so that the active ingredients wrapped in the cell wall and the cell membrane are released, so that the active ingredients in the Arisaema ciliata slices are dissolved in water faster and more completely, thereby improving the extraction effect of the Arisaema ciliata slices and improving the quality of the Arisaema ciliata formula granules.

[0025] In some embodiments of the present invention, Figure 3 As shown, step S200, decocting and extracting to obtain a filtrate of Arisaema ciliata, comprises: Step S210, decoct and extract at least once in the extraction container, and combine to obtain a filtrate of Arisaema ciliata. For example, decoct and extract once, twice, three times, or four times on the Arisaema ciliata slices.

[0026] In this embodiment, when extracting the active ingredients in Arisaema ciliata, the concentration difference of the active ingredients inside and outside the cells of Arisaema ciliata slices is used to diffuse the active ingredients in the cells into the water. As the active ingredients in the water increase, the diffusion rate of the active ingredients decreases. By replacing new water, the diffusion rate of the active ingredients increases, the diffusion rate of the active ingredients is improved, thereby reducing the extraction time of the active ingredients, and then improving the quality of Arisaema ciliata formula granules.

[0027] In some embodiments of the present invention, Figure 3 As shown, in step S500, after the dry paste powder and the dextrin of the second preset ratio are mixed and dry pressed to obtain the bile linseed formula granules, the following further comprises: Step S600, optimizing the preparation method of Arisaema consanguineum formula granules.

[0028] In this embodiment, the preparation method of the Arisaema ciliata formula granules also includes the optimization of the preparation method. The soaking process and the decoction process of the Arisaema ciliata decoction pieces are optimized to study the best preparation method of the Arisaema ciliata formula granules, thereby improving the quality of the Arisaema ciliata formula granules. In addition, optimizing the preparation method of the Arisaema ciliata formula granules can save preparation time, reduce energy consumption, and thereby improve the preparation efficiency of the Arisaema ciliata formula granules.

[0029] In some embodiments of the present invention, step S100, putting Arisaema ciliata slices and water into an extraction container according to a first preset ratio to soak the Arisaema ciliata slices, comprises: Step S110, using a granulator to cut the Arisaema ciliata slices into Arisaema ciliata granules, adding the Arisaema ciliata granules and water into an extraction container according to a first preset ratio, and soaking the Arisaema ciliata granules.

[0030] In this embodiment, when preparing the Arisaema consanguineum formula granules, the Arisaema consanguineum slices are first cut into Arisaema consanguineum granules, and the Arisaema consanguineum granules are soaked in water. After soaking, the water is heated to boiling and decocted to obtain the Arisaema consanguineum filtrate. The Arisaema consanguineum filtrate is concentrated and dried to obtain a dry paste powder. The dry paste powder is mixed with dextrin and then dry-pressed to obtain the Arisaema consanguineum formula granules. By cutting the Arisaema consanguineum slices into Arisaema consanguineum granules and soaking the Arisaema consanguineum granules in water, the contact area between the Arisaema consanguineum granules and the water is larger, thereby increasing the dissolution rate of the active ingredients in the Arisaema consanguineum granules. The active ingredients in the Arisaema consanguineum slices are dissolved in water faster and more completely, thereby improving the extraction effect of the Arisaema consanguineum slices.

[0031] In some embodiments of the present invention, step S600, optimizing the preparation method of Arisaema ciliata formula granules, comprises: Step S650, conducting a preparation test of the cholanthus lindracena formula granules on the aperture and the number of granulation of the granulator, analyzing the paste yield and uracil content, and performing bile acid identification to determine the optimal aperture and the optimal number of granulation of the granulator.

[0032] In this embodiment, the aperture and number of granulation times of the granulator when cutting the Arisaema consanguineum slices are optimized.

[0033] In some embodiments of the present invention, the aperture of the pelletizer is 4 mm to 8 mm, for example, 4 mm, 5 mm, 6 mm, 7 mm or 8 mm. The number of pelletizing times is 1 to 3 times, for example, the number of pelletizing times is 1, 2 or 3 times.

[0034] In some embodiments of the present invention, Figure 2 As shown, step S600, optimizing the preparation method of Arisaema ciliata formula granules, comprises: Step S610, performing single factor test and orthogonal test on the number of decoctions, decoction time, first preset ratio, and soaking time, and obtaining the paste yield, maximum paste yield, uracil content, maximum uracil content, bile acid identification score, and maximum bile acid identification score for each group of experiments.

[0035] Step S620, determining a comprehensive score according to the cream yield, the maximum cream yield, the uracil content, the maximum uracil content, the bile acid identification score and the maximum bile acid identification score.

[0036] Step S630, comparing the comprehensive scores, and taking the process conditions corresponding to the highest comprehensive score as the optimal preparation conditions for the Arisaema consanguineum formula granules.

[0037] Step S640, preparing and analyzing the optimized Arisaema ciliata formula granule sample using the optimized process conditions of Arisaema ciliata formula granule, and verifying the optimization result by comparing with the control sample.

[0038] In the present embodiment, a single factor test is performed with the number of decoctions, the time of decoction, the first preset ratio, and the time of soaking as variables, and the number of decoctions, the time of decoction, the first preset ratio, and the time range of soaking are obtained, which are used to design an orthogonal test table. According to the orthogonal test table, 9 groups of orthogonal tests are performed, and the cream yield, uracil content, and bile acid identification score in each group of tests are measured respectively to determine the maximum cream yield, the maximum uracil content, and the highest bile acid identification score. The comprehensive score of each group of test results is calculated according to the cream yield, the maximum cream yield, the uracil content, the maximum uracil content, the bile acid identification score, and the highest bile acid identification score. The process conditions corresponding to the test group with the highest comprehensive score are the optimal preparation conditions for the gallbladder aconite formula granules. The gallbladder aconite formula granule sample is prepared using the optimal preparation conditions and compared with the control medicinal materials to verify the optimization results.

[0039] The number of decoctions of Arisaema ciliata slices, the decoction time, the first preset ratio, and the soaking time are optimized to study the best preparation method of Arisaema ciliata formula granules, thereby improving the quality of Arisaema ciliata formula granules. In addition, optimizing the preparation method of Arisaema ciliata formula granules can save preparation time, reduce energy consumption, and thereby improve the preparation efficiency of Arisaema ciliata formula granules.

[0040] In some embodiments of the present invention, the first preset ratio is the weight ratio of water to Arisaema consanguineum decoction pieces, and the first preset ratio is 10:1 to 15:1. For example, the first preset ratio is 10:1, 11:1, 12:1, 13:1, 14:1 or 15:1.

[0041] In this embodiment, after optimizing the Arisaema consanguineum formula granules, the first preset ratio has little effect on the Arisaema consanguineum formula granules. Therefore, under the premise of meeting the quality of the Arisaema consanguineum formula granules, the amount of water added is reduced, thereby saving the preparation cost of the Arisaema consanguineum formula granules.

[0042] Preferably, the first preset ratio is 10:1.

[0043] In some embodiments of the present invention, the second preset ratio is the weight ratio of dextrin to dry paste powder, and the second preset ratio is less than or equal to 1. For example, the second preset ratio is 0, 0.2, 0.4, 0.6, 0.8 or 1.

[0044] In this embodiment, the amount of dextrin used in the preparation of Arisaema ciliata formula granules does not exceed 11% of the weight of Arisaema ciliata decoction pieces.

[0045] In some embodiments of the present invention, the soaking time is 0.5 h to 2 h. For example, the soaking time is 0.5 h, 1 h, 1.5 h or 2 h.

[0046] In this embodiment, the Arisaema ciliata decoction pieces are fully soaked in water, so that the active ingredients in the medicinal materials are more easily extracted by water during the decoction process, and reasonable soaking can reduce the loss of some ingredients caused by high temperature during the decoction process.

[0047] Preferably, the soaking time is 2 hours.

[0048] In some embodiments of the present invention, the soaking temperature is 10° C. to 40° C. For example, the soaking temperature is 10° C., 20° C., 30° C. or 40° C.

[0049] In some embodiments of the present invention, the decoction temperature is 98° C. to 100° C. For example, the decoction temperature is 98° C., 99° C. or 100° C.

[0050] In some embodiments of the present invention, the decocting time is 0.5 h to 2 h. For example, the decocting time is 0.5 h, 1 h, 1.5 h or 2 h.

[0051] Preferably, the decocting time is 1 hour.

[0052] In some embodiments of the present invention, in step S300, the filtrate of Arisaema cinerea is concentrated to obtain a clear paste, and the concentration temperature is 50° C. to 85° C. For example, the concentration temperature is 50° C., 60° C., 70° C., 80° C., 85° C. The relative density of the clear paste is 1.01 to 1.10.

[0053] In this embodiment, the clear paste is prepared by decompression concentration, and the filtrate of Arisaema ciliata is concentrated in a vacuum environment. No high temperature is required during concentration to prevent the high temperature from affecting the filtrate of Arisaema ciliata. The relative density of the clear paste is the ratio of the density of the clear paste to the density of water at the same temperature. The relative density of the clear paste affects the effect of the spray. If the relative density of the clear paste is too large, it will cause difficulty in spraying, thereby affecting the drying of the clear paste.

[0054] Furthermore, when the Arisaema consanguineum filtrate is concentrated, the steam pressure does not exceed 0.12MPa and the vacuum degree is -0.03MPa to -0.09MPa.

[0055] In some embodiments of the present invention, in step S400, the clear paste is spray-dried to obtain a dry paste powder, the air inlet temperature is 120°C to 180°C, for example, the air inlet temperature is 120°C, 130°C, 140°C, 150°C, 160°C, 170°C or 180°C. The air outlet temperature is 80°C to 110°C, for example, the air outlet temperature is 80°C, 90°C, 100°C or 110°C. The liquid inlet frequency is 5.0Hz to 30.0Hz, for example, the liquid inlet frequency is 5.0Hz, 10Hz, 15Hz, 20Hz, 25Hz or 30Hz.

[0056] In this embodiment, a spray dryer is used to dry the dry paste powder, so that the clear paste is dried instantly, the drying time of the clear paste is reduced, and the production cost of the cholerae nanxing formula granules is reduced. In addition, most of the heat in the spray drying process is used to evaporate the water in the clear paste, and the heating time of the clear paste is extremely short, and the quality of the dry paste powder will not be affected by the high temperature.

[0057] In some embodiments of the present invention, in step S500, dry paste powder and a second preset ratio of dextrin are mixed and then dry-pressed to obtain the Arisaema consanguineum formula granules, using a dry pressing granulation method, with a 12-mesh sieve for granulation and 10 and 40 meshes for whole granulation.

[0058] The conveying rotation speed is 20 r / min to 230 r / min, for example, the conveying rotation speed is 20 r / min, 50 r / min, 100 r / min, 150 r / min, 200 r / min or 230 r / min.

[0059] The pressure roller speed is 3 r / min to 40 r / min, for example, the pressure roller speed is 3 r / min, 5 r / min, 10 r / min, 15 r / min, 20 r / min, 25 r / min, 30 r / min, 35 r / min or 40 r / min.

[0060] The granulation speed is 20 r / min to 230 r / min. For example, the granulation speed is 20 r / min, 50 r / min, 100 r / min, 150 r / min, 200 r / min or 230 r / min.

[0061] In some embodiments of the present invention, in step S620, the comprehensive score is determined according to the cream yield, the maximum cream yield, the uracil content, the maximum uracil content, the bile acid identification score and the highest bile acid identification score. The calculation formula of the comprehensive score is: Wherein, W is the comprehensive score. A1 is the cream yield, A0 is the maximum cream yield, a is the first coefficient. B1 is the uracil content, B0 is the maximum uracil content, b is the second coefficient; C1 is the bile acid identification score, C0 is the highest bile acid identification score, and c is the third coefficient.

[0062] In some embodiments of the present invention, the first coefficient is 0.2, the second coefficient is 0.5, and the third coefficient is 0.3.

[0063] In some embodiments of the present invention, when determining the cream yield, take the concentrated solution of Arisaema cinerea, filter it, and then take 50 mL of the filtrate and put it into an evaporating dish dried to constant weight, evaporate it in a water bath, and dry it at 105°C for 3 hours. After drying, put it into a dry cooler to cool for 1 hour, and then weigh it quickly. The calculation formula for the cream yield is:

[0064] Wherein, A1 is the yield of the paste, in %, M1 is the sum of the weight of the constant-weight evaporating dish and the concentrated solution, in g. M2 is the weight of the constant-weight evaporating dish, in g. V is the total volume of the concentrated solution, in L. M is the weight of the decoction piece, in kg.

[0065] The embodiment of the present invention also provides a kind of Arisaema consanguineum formula granules prepared by the preparation method in any one of the above embodiments.

[0066] The present invention is further described below by means of specific implementation methods. The following examples are specific implementation methods of the present invention, but the implementation methods of the present invention are not limited to the following examples. Example

[0067] Step S11, weigh 1.5 kg of Arisaema ciliata slices and place them in an extraction container, add 12 times the amount of water and soak for 1 hour.

[0068] Step S12, heating water to 100°C and then boiling for 1 hour to obtain the filtrate of Arisaema ciliata. Take 50 mL of the filtrate, place it in an evaporating dish that has been dried to constant weight, evaporate it in a water bath, dry it at 105°C for 3 hours, cool it in a dry cooler for 1 hour, quickly weigh it, and calculate the paste rate.

[0069] Step S13, concentrating the filtrate of Arisaema ciliata, with a steam pressure of 0.1 MPa, a vacuum degree of -0.06 MPa, and a concentration temperature of 65°C to obtain a clear paste with a relative density of 1.01.

[0070] Step S14, spray-dry and dry-press the clear paste to obtain the cholanthus sutchuenensis formula granules. Grind the cholanthus sutchuenensis formula granules, take 0.1 g into a conical flask, add 20 mL of 10% methanol, and ultrasonically treat for 30 minutes at a power of 250 W and a frequency of 40 kHz, cool, weigh again, make up the lost weight with 10% methanol, shake well, filter to obtain a sample solution, and inject into liquid chromatography to determine the uracil content.

[0071] Step S15, grind the cholerae formula granules, take 2.0g in a conical flask, add 30mL of methanol, ultrasonically treat for 30 minutes, filter, evaporate the filtrate, add 1mL of methanol to the residue to dissolve it, and obtain a sample solution. 10μL of the solution and 2μL of the reference solution are respectively spotted on the same silica gel G thin layer plate, and the upper layer solution of n-hexane-ethyl acetate-acetic acid-methanol (20:25:2:3) is used as the developing agent, developed, taken out, dried, sprayed with 10% phosphomolybdic acid ethanol solution, heated at 105°C until the spots are clearly colored, and the strength of the spots is scored. Take the bile acid reference substance, add methanol to make a solution containing 1mg per 1mL, as the bile acid reference solution, and the identification method of the bile acid reference solution is the same as the identification method of the sample solution. The identification score of the bile acid reference substance is 100 points.

[0072] Step S16, calculating a comprehensive score according to the cream yield, uracil content and bile acid identification score.

[0073] The test showed that the yield of the clear paste was 14.1%, the content of uracil in the Arisaema consanguineum formula granules was 0.61 mg / g, the bile acid identification score of the Arisaema consanguineum formula granules was 52, and the comprehensive score was 0.768. Example

[0074] Step S21, weigh 1.5 kg of Arisaema ciliata slices and place them in an extraction container, add 15 times the amount of water and soak for 0.5 h.

[0075] Step S22, heat the water to 100°C and start decocting, decoct for 1 hour, perform decocting twice, and obtain the filtrate of Arisaema ciliata. Take 50 mL of the filtrate, place it in an evaporating dish dried to constant weight, evaporate it in a water bath, dry it at 105°C for 3 hours, cool it in a dry cooler for 1 hour, quickly weigh it, and calculate the paste rate.

[0076] The subsequent steps are the same as in Example 1.

[0077] The test showed that the yield of the clear paste was 16.1%, the uracil content in the Arisaema consanguineum formula granules was 0.55 mg / g, the bile acid identification score of the Arisaema consanguineum formula granules was 48, and the comprehensive score was 0.728. Example

[0078] Step S31, weigh 1.5 kg of Arisaema ciliata slices and place them in an extraction container, add 10 times the amount of water and soak for 2 hours.

[0079] Step S32, heat the water to 100°C and start decocting, decoct for 1 hour, and decoct for 3 times to obtain the filtrate of Arisaema ciliata. Take 50 mL of the filtrate, place it in an evaporating dish that has been dried to constant weight, evaporate it in a water bath, dry it at 105°C for 3 hours, cool it in a dry cooler for 1 hour, quickly weigh it, and calculate the paste rate.

[0080] The subsequent steps are the same as in Example 1.

[0081] The test showed that the yield of the clear paste was 19.2%, the uracil content in the Arisaema consanguineum formula granules was 0.72 mg / g, the bile acid identification score of the Arisaema consanguineum formula granules was 51, and the comprehensive score was 0.886. Example

[0082] Step S41, weigh 15 kg of Arisaema ciliata slices and place them in an extraction container, add 10 times the amount of water and soak for 2 hours.

[0083] Step S42, heat the water to 100°C and start decocting, decoct for 1 hour, and decoct for 3 times to obtain the filtrate of Arisaema ciliata. Take 50 mL of the filtrate, place it in an evaporating dish that has been dried to constant weight and evaporate it in a water bath, dry it at 105°C for 3 hours, cool it in a dry cooler for 1 hour, quickly weigh it, and calculate the paste rate.

[0084] Step S43, concentrating the filtrate of Arisaema consanguineum with a steam pressure of 0.1 MPa, a vacuum degree of -0.06 MPa, and a concentration temperature of 65°C to obtain a clear paste with a relative density of 1.01.

[0085] Step S44, taking the clear paste, spray drying and dry pressing to obtain Arisaema consanguineum formula granules.

[0086] Step S45, grind the granules of the formula of Arisaema confusa into fine powder, take 0.1 g into a conical flask, add 20 mL of 10% methanol, and ultrasonically treat for 30 minutes at a power of 250 W and a frequency of 40 kHz, cool, weigh again, make up the lost weight with 10% methanol, shake well, filter to obtain a solution, and inject into liquid chromatography to obtain a characteristic spectrum. Take a control medicinal material, obtain a control solution according to the same method, and inject into liquid chromatography to obtain a control characteristic spectrum.

[0087] Step 46, grind the cholerae formula granules, take 2.0g in a conical flask, add 30mL of methanol, ultrasonically treat for 30 minutes, filter, evaporate the filtrate, add 1mL of methanol to the residue to dissolve it, and obtain a sample solution. Take 10μL of the solution and 2μL of the reference solution and spot them on the same silica gel G thin layer plate, use the upper layer solution of n-hexane-ethyl acetate-acetic acid-methanol (20:25:2:3) as the developing agent, develop, take out, dry, spray with 10% phosphomolybdic acid ethanol solution, heat at 105°C until the spots are clearly colored, and score the strength of the spots. Take the bile acid reference, add methanol to make a solution containing 1mg per 1mL, as the bile acid reference solution, the identification method of the bile acid reference solution is the same as the identification method of the sample solution. The identification score of the bile acid reference is 100 points.

[0088] According to the test results, when preparing the formula granules of Arisaema consanguineum, the granules were decocted three times, decocted for 1 hour, soaked for 2 hours, and 10 times the amount of water was added each time. The extraction process and results were relatively stable. Figure 4 is the characteristic spectrum of the dannanxing formula granules and the reference medicinal material. Among them, R is the characteristic spectrum of the reference medicinal material. M1, M2 and M3 are the characteristic spectra of the dannanxing formula granules prepared by the same preparation method and measured multiple times. Figure 4 As shown, the peak retention time of S of the Cholecalciferol formula granules prepared according to the preferred production process is consistent with that of the reference medicinal material uracil, the relative retention time of peaks 1 to 4 and S peak is within the range of ±10% of the specified value, and the relative retention time of peaks 5 to 8 and S peak is within the range of ±15% of the specified value, which meets the requirements of the Henan Provincial Drug Standard for Cholecalciferol Formula Granules. This shows that the preferred process can stably produce products that meet the established requirements and is suitable for commercial production.

[0089] Figure 5 The figure is a thin layer chromatogram of the bile acid reference substance and the bile acid reference substance. The spot on the far right is the spot of the bile acid reference substance, and the spot on the left is the spot obtained from multiple tests of the bile acid reference substance prepared by the same preparation method. Figure 5 As shown, at the corresponding position of the spot of the bile acid reference substance, the identification spot of the Arisaema consanguineum formula granules is visible, which is in line with the drug standard requirements for Arisaema consanguineum formula granules. Example

[0090] Step S51, granulate the Arisaema ciliata slices three times in a granulator with a pore size of 4 mm to obtain Arisaema ciliata granules.

[0091] Step S52, put the chondriasis granules into an extraction container, add 10% of the weight of the chondriasis granules in water, soak for 0.5h, and then boil for 0.5h to obtain the chondriasis filtrate. Take 50mL of the filtrate, place it in an evaporating dish that has been dried to constant weight and evaporate it in a water bath, dry it at 105°C for 3h, cool it in a dry cooler for 1h, quickly weigh it, and calculate the paste rate.

[0092] Step S53, concentrating the filtrate of Arisaema consanguineum with a steam pressure of 0.1 MPa, a vacuum degree of -0.06 MPa, and a concentration temperature of 65°C to obtain a clear paste with a relative density of 1.01.

[0093] Step S54, take the clear paste for spray drying and dry pressing to obtain the cholanthus sibiricum formula granules. Grind the cholanthus sibiricum formula granules, take 0.1g into a conical flask, add 20mL of 10% methanol, ultrasonically treat for 30 minutes at a power of 250W and a frequency of 40kHz, cool, weigh again, make up the lost weight with 10% methanol, shake well, filter to obtain a sample solution, and inject into liquid chromatography to determine the uracil content.

[0094] Step S55, grind the cholerae formula granules, take 2.0g in a conical flask, add 30mL of methanol, ultrasonically treat for 30 minutes, filter, evaporate the filtrate, add 1mL of methanol to the residue to dissolve it, and obtain a sample solution. Take 10μL of the solution and 2μL of the reference solution and spot them on the same silica gel G thin layer plate, use the upper layer solution of n-hexane-ethyl acetate-acetic acid-methanol (20:25:2:3) as the developing agent, develop, take out, dry, spray with 10% phosphomolybdic acid ethanol solution, heat at 105°C until the spots are clearly colored, and score the strength of the spots. Take the bile acid reference, add methanol to make a solution containing 1mg per 1mL, as the bile acid reference solution, the identification method of the bile acid reference solution is the same as the identification method of the sample solution.

[0095] The test showed that the yield of the clear paste was 12%, the content of uracil in the Arisaema consanguineum granules was 0.3 mg / g, and the identification spots of bile acid in the Arisaema consanguineum granules were visible, which was in line with the drug standard requirements for the Arisaema consanguineum granules.

[0096] At this point, those skilled in the art should recognize that, although multiple exemplary embodiments of the present invention have been shown and described in detail herein, many other variations or modifications that conform to the principles of the present invention can still be directly determined or derived based on the content disclosed in the present invention without departing from the spirit and scope of the present invention. Therefore, the scope of the present invention should be understood and recognized as covering all these other variations or modifications.

Claims

1. A method for preparing a granule of Arisaema ciliata, characterized in that: The following steps are involved: Putting Arisaema ciliata slices and water into an extraction container according to a first preset ratio to soak the Arisaema ciliata slices; Decoction and extraction to obtain the filtrate of Arisaema ciliata; The filtrate of Arisaema ciliata is concentrated to obtain a clear paste; Taking the clear paste and spray drying it to obtain dry paste powder; The dry paste powder is mixed with dextrin in a second preset ratio and then dry-pressed to prepare the bile linden formula granules.

2. The preparation method according to claim 1, characterized in that: The decoction and extraction to obtain the Arisaema ciliata filtrate comprises: The extraction is performed at least once in the extraction container, and the Arisaema ciliata filtrate is obtained by decocting and extracting.

3. The preparation method according to claim 1, characterized in that: The first preset ratio is the weight ratio of the water to the Arisaema ciliata decoction pieces, and the first preset ratio is 10:1 to 15:1; The second preset ratio is a weight ratio of the dextrin to the dry paste powder, and the second preset ratio is less than or equal to 1; The soaking time is 0.5h to 2h, and the soaking temperature is 10°C to 40°C; The decoction temperature is 98°C to 100°C, and the decoction time is 0.5h to 2h; In the step of concentrating the filtrate of Arisaema confusa to obtain a clear paste, the concentration temperature is 50° C. to 85° C.; the relative density of the clear paste is 1.01 to 1.10; In the step of spray drying the clear paste to obtain dry paste powder, the inlet air temperature is 120°C to 180°C, and the outlet air temperature is 80°C to 110°C.

4. The preparation method according to claim 1, characterized in that: After the dry paste powder is mixed with a second preset ratio of dextrin and then dry-pressed to obtain the bile linseed formula granules, the method further comprises: The preparation method of the Arisaema consanguineum formula granules is optimized.

5. The preparation method according to claim 4, characterized in that: The step of adding the Arisaema ciliata slices and water into an extraction container according to a first preset ratio to soak the Arisaema ciliata slices comprises: The Arisaema ciliata decoction pieces are cut into Arisaema ciliata granules by using a granulator, and the Arisaema ciliata granules and water are put into an extraction container according to the first preset ratio to soak the Arisaema ciliata granules.

6. The preparation method according to claim 5, characterized in that: The method for preparing the Arisaema consanguineum formula granules is optimized, comprising: The aperture and granulation times of the pelletizer were tested for the preparation of the bile arborvitae formula granules, the paste yield and uracil content were analyzed, and bile acid identification was performed to determine the optimal aperture and optimal granulation times of the pelletizer.

7. The preparation method according to claim 4, characterized in that: The method for preparing the Arisaema consanguineum formula granules is optimized, comprising: Single factor test and orthogonal test are performed on the number of decoctions, the decoction time, the first preset ratio, and the soaking time to obtain the paste yield, maximum paste yield, uracil content, maximum uracil content, bile acid identification score, and maximum bile acid identification score of each group of experiments; Determining a comprehensive score according to the cream yield rate, the maximum cream yield rate, the uracil content, the maximum uracil content, the bile acid identification score, and the highest bile acid identification score; Comparing the comprehensive scores, taking the process conditions corresponding to the highest comprehensive score as the optimal preparation conditions of the Dannanxing formula granules; Using the optimized process conditions of the Arisaema consanguineum formula granules, the optimized Arisaema consanguineum formula granules samples were prepared and analyzed, and the optimization results were verified by comparing with the control samples.

8. The preparation method according to claim 7, characterized in that: In the step of determining a comprehensive score according to the cream yield, the maximum cream yield, the uracil content, the maximum uracil content, the bile acid identification score and the highest bile acid identification score, the calculation formula of the comprehensive score is: ; Among them, W is the comprehensive score; A1 is the cream yield rate, A0 is the maximum cream yield rate, a is the first coefficient; B1 is the uracil content, B0 is the maximum uracil content, b is the second coefficient; C1 is the bile acid identification score, C0 is the highest bile acid identification score, and c is the third coefficient.

9. The preparation method according to claim 8, characterized in that: The first coefficient is 0.2; The second coefficient is 0.5; The third coefficient is 0.

3.

10. A granule of Arisaema ciliata prepared by the preparation method according to any one of claims 1 to 9.